AI Analysis AI Analysis of ENZN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ENZN to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Weaker technical forecast for Enzon Pharmaceuticals as stock downgraded to Sell Candidate
(Updated on Jul 02, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 02, 2026

No changes to the price of Enzon Pharmaceuticals stock on the last trading day (Thursday, 2nd Jul 2026). During the last trading day the stock fluctuated 0% from a day low at $4.75 to a day high of $4.75. The price has fallen in 7 of the last 10 days and is down by -15.18% for this period.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $4.62 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 85.22% during the next 3 months and, with a 90% probability hold a price between $8.56 and $18.98 at the end of this 3-month period.

ENZN Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 01, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Enzon Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.99 and $5.60. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Enzon Pharmaceuticals stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 2.62%

Enzon Pharmaceuticals is oversold on RSI14 (17). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ENZN) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Enzon Pharmaceuticals to open at $4.75, and during the day (based on 14 day Average True Range), to move between $4.66 and $4.84, which gives a possible trading interval of +/-$0.171 (+/-3.67%) up or down from last closing price. If Enzon Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 3.67% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $5.50, some $0.750 (15.79%) from the current price of $4.75, our system finds the risk reward not very attractive.

Is Enzon Pharmaceuticals stock A Buy?

The Enzon Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe Enzon Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -1.616 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $4.75 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ENZN Performance

Trading levels for ENZN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 4.75 -
R2 4.75 -
R1 4.75 -
Price 4.75
S1 4.75 -
S2 4.75 -
S3 4.75 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.85 23.16%
R2 5.75 21.05%
R1 5.50 15.79%
Price 4.75
S1 0 -
S2 0 -
S3 0 -

ENZN Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Sep 30, 2019 Sep 30, 2019 Oct 15, 2019 $0.120 52.17%
2 Feb 20, 2019 Feb 20, 2019 Feb 20, 2019 $0.0600 26.09%
3 Sep 29, 2017 Sep 29, 2017 Sep 29, 2017 $0.150 62.51%
4 Dec 13, 2016 Dec 13, 2016 Dec 13, 2016 $0.150 44.72%
5 Dec 30, 2015 Dec 30, 2015 Dec 30, 2015 $0.250 36.23%

FAQ

What is the symbol for Enzon Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Enzon Pharmaceuticals is ENZN and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell Enzon Pharmaceuticals Stock?
The Enzon Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe Enzon Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Enzon Pharmaceuticals Stock?
Enzon Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Enzon Pharmaceuticals Stock.

What's the current price of Enzon Pharmaceuticals Stock?
As of the end of day on the Jul 02, 2026, the price of an Enzon Pharmaceuticals (ENZN) share was $4.75.

What is the 52-week high and low for Enzon Pharmaceuticals Stock?
The 52-week high for Enzon Pharmaceuticals Stock is $11.70 and the 52-week low is $0.0588.

What is the market capitalization of Enzon Pharmaceuticals Stock?
As of the Jul 02, 2026, the market capitalization of Enzon Pharmaceuticals is 31.408M.
Click to get the best stock tips daily for free!
ABOUT ENZON PHARMACEUTICALS
Enzon Pharmaceuticals
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey....
GOLDEN STAR
Ticker Change Signal Date
B
BXDC
$21.71
1.11% Jun 29
SRPT
$17.02
13.28% Jun 29
OSIS
$218.29
1.59% Jun 26
NMRK
$15.02
4.66% Jun 24
JLL
$299.78
9.23% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE